{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:34:00Z","timestamp":1782977640993,"version":"3.54.5"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,10,24]],"date-time":"2008-10-24T00:00:00Z","timestamp":1224806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Community Health"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s10900-008-9134-4","type":"journal-article","created":{"date-parts":[[2008,10,23]],"date-time":"2008-10-23T12:18:08Z","timestamp":1224764288000},"page":"135-143","source":"Crossref","is-referenced-by-count":5,"title":["The Nurse\u2019s Role in the Prevention of Cervical Cancer Among Underserved and Minority Populations"],"prefix":"10.1007","volume":"34","author":[{"given":"Norma Martinez","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelita G.","family":"Cantu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,24]]},"reference":[{"key":"9134_CR1","unstructured":"Ries, L., Harkins, D., Krapcho, M., Mariotto, A., Miller, B. A., Feuer, E. J., et al. (Eds.), SEER Cancer Statistics Review, 1975\u20132004. Bethesda: National Cancer Institute, based on November 2005 SEER data submission, posted to the SEER web site. Available at http:\/\/seer.cancer.gov\/csr\/1975_2004\/ . Accessed 3 February 2008."},{"key":"9134_CR2","unstructured":"ACS. American Cancer Society: Cancer Facts & Figures. (2008). Available at http:\/\/www.cancer.org\/downloads\/STT\/2008CAFFfinalsecured.pdf . Accessed 1 April 2008."},{"issue":"1","key":"9134_CR3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers, J. M., Jacobs, M. V., Manos, M. M., et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189(1), 12\u201319.","journal-title":"Journal of Pathology"},{"issue":"4","key":"9134_CR4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J., & Shah, K. V. (2002). The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology, 55(4), 244\u2013265.","journal-title":"Journal of Clinical Pathology"},{"issue":"8","key":"9134_CR5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","volume":"297","author":"EF Dunne","year":"2007","unstructured":"Dunne, E. F., Unger, E. R., Sternberg, M., et al. (2007). Prevalence of HPV infection among females in the United States. Jama, 297(8), 813\u2013819.","journal-title":"Jama"},{"key":"9134_CR6","unstructured":"CDC. (2007). The pink book: Epidemiology and prevention of vaccine preventable diseases. Updated 10th ed."},{"issue":"2","key":"9134_CR7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1055-9965.EPI-03-0166","volume":"13","author":"RP Viscidi","year":"2004","unstructured":"Viscidi, R. P., Schiffman, M., Hildesheim, A., et al. (2004). Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: Results from a population-based study in Costa Rica. Cancer Epidemiology, Biomarkers and Prevention, 13(2), 324\u2013327.","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"9134_CR8","unstructured":"U.S. Census Bureau. (2004). U.S. interim projections by age, sex, race, and hispanic origin. Available at http:\/\/www.census.gov\/ipc\/www\/usinterimproj\/ . Accessed 5 March 2008."},{"issue":"1","key":"9134_CR9","first-page":"7","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow, D., Castle, P. E., Cox, J. T., et al. (2007). American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA: A Cancer Journal for Clinicians, 57(1), 7\u201328.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"6","key":"9134_CR10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.AOG.0000159549.56601.75","volume":"105","author":"VB Benard","year":"2005","unstructured":"Benard, V. B., Lawson, H. W., Eheman, C. R., Anderson, C., & Helsel, W. (2005). Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstetrics and Gynecology, 105(6), 1323\u20131328.","journal-title":"Obstetrics and Gynecology"},{"key":"9134_CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith, J. S., Lindsay, L., Hoots, B., et al. (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. International Journal of Cancer, 121, 621\u2013632.","journal-title":"International Journal of Cancer"},{"key":"9134_CR12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"EM Villiers de","year":"2004","unstructured":"de Villiers, E. M., Fauquet, C., Broker, T. R., Bernard, H. U., & zur Hausen, H. (2004). Classification of papillomaviruses. Virology, 324, 17\u201327.","journal-title":"Virology"},{"issue":"5","key":"9134_CR13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","volume":"98","author":"X Castellsague","year":"2006","unstructured":"Castellsague, X., Diaz, M., de Sanjose, S., et al. (2006). Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention. Journal of the National Cancer Institute, 98(5), 303\u2013315.","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"9134_CR14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D","volume":"86","author":"AP Vizcaino","year":"2000","unstructured":"Vizcaino, A. P., Moreno, V., Bosch, F. X., et al. (2000). International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. International Journal of Cancer, 86(3), 429\u2013435.","journal-title":"International Journal of Cancer"},{"issue":"4","key":"9134_CR15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U","volume":"75","author":"AP Vizcaino","year":"1998","unstructured":"Vizcaino, A. P., Moreno, V., Bosch, F. X., Munoz, N., Barros-Dios, X. M., & Parkin, D. M. (1998). International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. International Journal of Cancer, 75(4), 536\u2013545.","journal-title":"International Journal of Cancer"},{"issue":"6","key":"9134_CR16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/ijc.20678","volume":"113","author":"S Bulk","year":"2005","unstructured":"Bulk, S., Visser, O., Rozendaal, L., Verheijen, R. H., & Meijer, C. J. (2005). Cervical cancer in the Netherlands 1989\u20131998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. International Journal of Cancer, 113(6), 1005\u20131009.","journal-title":"International Journal of Cancer"},{"issue":"1","key":"9134_CR17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1097-0142(20010225)93:1<8::AID-CNCR9001>3.0.CO;2-K","volume":"93","author":"JF Krane","year":"2001","unstructured":"Krane, J. F., Granter, S. R., Trask, C. E., Hogan, C. L., & Lee, K. R. (2001). Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: A study of 49 cases. Cancer, 93(1), 8\u201315.","journal-title":"Cancer"},{"issue":"4","key":"9134_CR18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/bjc.1995.172","volume":"71","author":"H Mitchell","year":"1995","unstructured":"Mitchell, H., Medley, G., Gordon, I., & Giles, G. (1995). Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: No strong evidence of benefit. British Journal of Cancer, 71(4), 894\u2013897.","journal-title":"British Journal of Cancer"},{"issue":"2","key":"9134_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/1097-0339(200008)23:2<127::AID-DC13>3.0.CO;2-I","volume":"23","author":"SS Raab","year":"2000","unstructured":"Raab, S. S. (2000). Can glandular lesions be diagnosed in pap smear cytology? Diagnostic Cytopathology, 23(2), 127\u2013133.","journal-title":"Diagnostic Cytopathology"},{"key":"9134_CR20","first-page":"119","volume":"12","author":"M Einstein","year":"2001","unstructured":"Einstein, M., & Burk, R. (2001). Persistent human papillomavirus infection: Definitions and clinical implications. Papillomavirus Report, 12, 119.","journal-title":"Papillomavirus Report"},{"issue":"7364","key":"9134_CR21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","volume":"325","author":"SK Kjaer","year":"2002","unstructured":"Kjaer, S. K., van den Brule, A. J., Paull, G., et al. (2002). Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: Population based prospective follow up study. Bmj, 325(7364), 572.","journal-title":"Bmj"},{"issue":"2","key":"9134_CR22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)00300-3","volume":"70","author":"JL Benedet","year":"2000","unstructured":"Benedet, J. L., Bender, H., Jones, H, 3rd, Ngan, H. Y., & Pecorelli, S. (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. International Journal of Gynaecology and Obstetrics, 70(2), 209\u2013262.","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"9134_CR23","doi-asserted-by":"crossref","unstructured":"Wright, T. C., Jr. (2006). HPV DNA testing for cervical cancer screening. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynaecology and Obstetrics, 95(Suppl 1), S239\u2013S246.","DOI":"10.1016\/S0020-7292(06)60039-8"},{"issue":"Suppl 3","key":"9134_CR24","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.vaccine.2006.05.118","volume":"24","author":"TC Wright","year":"2006","unstructured":"Wright, T. C., Van Damme, P., Schmitt, H. J., & Meheus, A. (2006). Chapter 14: HPV vaccine introduction in industrialized countries. Vaccine, 24(Suppl 3), S122\u2013S131.","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"9134_CR25","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.vaccine.2005.09.002","volume":"24","author":"M Stanley","year":"2006","unstructured":"Stanley, M. (2006). Immune responses to human papillomavirus. Vaccine, 24(Suppl 1), S16\u2013S22.","journal-title":"Vaccine"},{"issue":"4","key":"9134_CR26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0952-7915(02)00354-0","volume":"14","author":"A Le Bon","year":"2002","unstructured":"Le Bon, A., & Tough, D. F. (2002). Links between innate and adaptive immunity via type I interferon. Current Opinion in Immunology, 14(4), 432\u2013436.","journal-title":"Current Opinion in Immunology"},{"key":"9134_CR27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","volume":"23","author":"AN Theofilopoulos","year":"2005","unstructured":"Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005). Type I interferons (alpha\/beta) in immunity and autoimmunity. Annual Review of Immunology, 23, 307\u2013336.","journal-title":"Annual Review of Immunology"},{"issue":"15","key":"9134_CR28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jnci\/djg018","volume":"95","author":"D Nardelli-Haefliger","year":"2003","unstructured":"Nardelli-Haefliger, D., Wirthner, D., Schiller, J. T., et al. (2003). Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. Journal of the National Cancer Institute, 95(15), 1128\u20131137.","journal-title":"Journal of the National Cancer Institute"},{"issue":"9","key":"9134_CR29","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1128\/JVI.00143-08","volume":"82","author":"PM Day","year":"2008","unstructured":"Day, P. M., Gambhira, R., Roden, R., Lowy, D. R., & Schiller, J. T. (2008). Mechanisms of HPV16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies. Journal of Virology, 82(9), 4638\u20134646.","journal-title":"Journal of Virology"},{"issue":"4","key":"9134_CR30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00262-007-0440-y","volume":"57","author":"MH Einstein","year":"2008","unstructured":"Einstein, M. H. (2008). Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines. Cancer Immunology, Immunotherapy, 57(4), 443\u2013451.","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"7","key":"9134_CR31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","volume":"298","author":"A Hildesheim","year":"2007","unstructured":"Hildesheim, A., Herrero, R., Wacholder, S., et al. (2007). Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: A randomized trial. Jama, 298(7), 743\u2013753.","journal-title":"Jama"},{"issue":"2","key":"9134_CR32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3201\/eid1402.070499","volume":"14","author":"HW Chesson","year":"2008","unstructured":"Chesson, H. W., Ekwueme, D. U., Saraiya, M., & Markowitz, L. E. (2008). Cost-effectiveness of human papillomavirus vaccination in the United States. Emerging Infectious Diseases, 14(2), 244\u2013251.","journal-title":"Emerging Infectious Diseases"},{"issue":"5","key":"9134_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.whi.2006.06.005","volume":"16","author":"RP Insinga","year":"2006","unstructured":"Insinga, R. P. (2006). Annual productivity costs due to cervical cancer mortality in the United States. Womens Health Issues, 16(5), 236\u2013242.","journal-title":"Womens Health Issues"},{"issue":"3","key":"9134_CR34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajog.2007.01.028","volume":"196","author":"RL Fleurence","year":"2007","unstructured":"Fleurence, R. L., Dixon, J. M., Milanova, T. F., & Beusterien, K. M. (2007). Review of the economic and quality-of-life burden of cervical human papillomavirus disease. American Journal of Obstetrics and Gynecology, 196(3), 206\u2013212.","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"9134_CR35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1477-7525-1-33","volume":"1","author":"T Pearman","year":"2003","unstructured":"Pearman, T. (2003). Quality of life and psychosocial adjustment in gynecologic cancer survivors. Health and Quality of Life Outcomes, 1(1), 33.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"9 Suppl","key":"9134_CR36","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/cncr.11681","volume":"98","author":"K Basen-Engquist","year":"2003","unstructured":"Basen-Engquist, K., Paskett, E. D., Buzaglo, J., et al. (2003). Cervical cancer. Cancer, 98(9 Suppl), 2009\u20132014.","journal-title":"Cancer"},{"issue":"8","key":"9134_CR37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1034\/j.1600-0412.2003.00165.x","volume":"82","author":"M Idestrom","year":"2003","unstructured":"Idestrom, M., Milsom, I., & Andersson-Ellstrom, A. (2003). Women\u2019s experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstetricia et Gynecologica Scandinavica, 82(8), 756\u2013761.","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"3","key":"9134_CR38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0002-9378(91)90304-A","volume":"165","author":"C Lerman","year":"1991","unstructured":"Lerman, C., Miller, S. M., Scarborough, R., Hanjani, P., Nolte, S., & Smith, D. (1991). Adverse psychologic consequences of positive cytologic cervical screening. American Journal of Obstetrics and Gynecology, 165(3), 658\u2013662.","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"9134_CR39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1258\/0956462961917618","volume":"7","author":"P Clarke","year":"1996","unstructured":"Clarke, P., Ebel, C., Catotti, D. N., & Stewart, S. (1996). The psychosocial impact of human papillomavirus infection: Implications for health care providers. International Journal of STD and AIDS, 7(3), 197\u2013200.","journal-title":"International Journal of STD and AIDS"},{"issue":"2","key":"9134_CR40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/01674829309084437","volume":"14","author":"A Filiberti","year":"1993","unstructured":"Filiberti, A., Tamburini, M., Stefanon, B., et al. (1993). Psychological aspects of genital human papillomavirus infection: A preliminary report. Journal of Psychosomatic Obstetrics and Gynaecology, 14(2), 145\u2013152.","journal-title":"Journal of Psychosomatic Obstetrics and Gynaecology"},{"issue":"7451","key":"9134_CR41","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/bmj.328.7451.1293","volume":"328","author":"E Maissi","year":"2004","unstructured":"Maissi, E., Marteau, T. M., Hankins, M., Moss, S., Legood, R., & Gray, A. (2004). Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: Cross sectional questionnaire study. Bmj, 328(7451), 1293.","journal-title":"Bmj"},{"issue":"12","key":"9134_CR42","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1471-0528.2004.00279.x","volume":"111","author":"K McCaffery","year":"2004","unstructured":"McCaffery, K., Waller, J., Forrest, S., Cadman, L., Szarewski, A., & Wardle, J. (2004). Testing positive for human papillomavirus in routine cervical screening: Examination of psychosocial impact. Bjog, 111(12), 1437\u20131443.","journal-title":"Bjog"},{"issue":"2","key":"9134_CR43","first-page":"110","volume":"48","author":"BD Reed","year":"1999","unstructured":"Reed, B. D., Ruffin, M. T., Gorenflo, D. W., & Zazove, P. (1999). The psychosexual impact of human papillomavirus cervical infections. Journal of Family Practice, 48(2), 110\u2013116.","journal-title":"Journal of Family Practice"},{"key":"9134_CR44","first-page":"65","volume":"21","author":"BL Andersen","year":"1996","unstructured":"Andersen, B. L. (1996). Stress and quality of life following cervical cancer. Journal of the National Cancer Institute. Monographs, 21, 65\u201370.","journal-title":"Journal of the National Cancer Institute. Monographs"},{"key":"9134_CR45","unstructured":"DATA 2010. The Healthy People 2010 database. The Centers for Disease Control and Prevention. Available at http:\/\/wonder.cdc.gov\/data2010\/ . Accessed 7 January 2008."},{"issue":"6","key":"9134_CR46","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ypmed.2004.01.009","volume":"38","author":"GD Coronado","year":"2004","unstructured":"Coronado, G. D., Thompson, B., Koepsell, T. D., Schwartz, S. M., & McLerran, D. (2004). Use of Pap test among Hispanics and non-Hispanic whites in a rural setting. Preventive Medicine, 38(6), 713\u2013722.","journal-title":"Preventive Medicine"},{"issue":"1","key":"9134_CR47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2006.07.008","volume":"104","author":"MG del Carmen","year":"2007","unstructured":"del Carmen, M. G., Findley, M., Muzikansky, A., et al. (2007). Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy. Gynecologic Oncology, 104(1), 70\u201376.","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"9134_CR48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cdp.2006.05.003","volume":"30","author":"I Alba De","year":"2006","unstructured":"De Alba, I., & Sweningson, J. M. (2006). English proficiency and physicians\u2019 recommendation of Pap smears among Hispanics. Cancer Detection and Prevention, 30(3), 292\u2013296.","journal-title":"Cancer Detection and Prevention"},{"issue":"6","key":"9134_CR49","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/01.AOG.0000143881.53058.81","volume":"104","author":"K Behbakht","year":"2004","unstructured":"Behbakht, K., Lynch, A., Teal, S., Degeest, K., & Massad, S. (2004). Social and cultural barriers to Papanicolaou test screening in an urban population. Obstetrics and Gynecology, 104(6), 1355\u20131361.","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"9134_CR50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.7326\/0003-4819-90-6-957","volume":"90","author":"JM Eisenberg","year":"1979","unstructured":"Eisenberg, J. M. (1979). Sociologic influences on decision-making by clinicians. Annals of Internal Medicine, 90(6), 957\u2013964.","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"9134_CR51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0749-3797(02)00499-3","volume":"23","author":"TT Nguyen","year":"2002","unstructured":"Nguyen, T. T., McPhee, S. J., Nguyen, T., Lam, T., & Mock, J. (2002). Predictors of cervical Pap smear screening awareness, intention, and receipt among Vietnamese-American women. American Journal of Preventive Medicine, 23(3), 207\u2013214.","journal-title":"American Journal of Preventive Medicine"},{"issue":"1","key":"9134_CR52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10552-004-1290-y","volume":"16","author":"SJ Newmann","year":"2005","unstructured":"Newmann, S. J., & Garner, E. O. (2005). Social inequities along the cervical cancer continuum: A structured review. Cancer Causes and Control, 16(1), 63\u201370.","journal-title":"Cancer Causes and Control"},{"issue":"4","key":"9134_CR53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1377\/hlthaff.19.4.65","volume":"19","author":"KA Phillips","year":"2000","unstructured":"Phillips, K. A., Mayer, M. L., & Aday, L. A. (2000). Barriers to care among racial\/ethnic groups under managed care. Health Affairs (Millwood), 19(4), 65\u201375.","journal-title":"Health Affairs (Millwood)"},{"issue":"1","key":"9134_CR54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1005192902137","volume":"25","author":"H Baer","year":"2000","unstructured":"Baer, H., Allen, S., & Braun, L. (2000). Knowledge of human papillomavirus infection among young adult men and women: Implications for health education and research. Journal of Community Health, 25(1), 67\u201378.","journal-title":"Journal of Community Health"},{"issue":"1","key":"9134_CR55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/jwh.1997.6.113","volume":"6","author":"JE Ramirez","year":"1997","unstructured":"Ramirez, J. E., Ramos, D. M., Clayton, L., Kanowitz, S., & Moscicki, A. B. (1997). Genital human papillomavirus infections: Knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health, 6(1), 113\u2013121.","journal-title":"J Womens Health"},{"issue":"S2","key":"9134_CR56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/cncr.22353","volume":"109","author":"EK Adams","year":"2007","unstructured":"Adams, E. K., Breen, N., & Joski, P. J. (2007). Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and pap test utilization among white, Hispanic, and African American women: 1996\u20132000. Cancer, 109(S2), 348\u2013358.","journal-title":"Cancer"},{"key":"9134_CR57","unstructured":"Ryerson, A. B., Benard, V. B., & Major, A. C. (2005). The National Breast and Cervical Cancer Early Detection Program: 1991\u20132002 National Report. Atlanta: The Centers for Disease Control and Prevention."},{"key":"9134_CR58","unstructured":"The Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program. Available at http:\/\/www.cdc.gov\/cancer\/nbccedp\/ . Accessed 29 March 2008."},{"key":"9134_CR59","unstructured":"Department of Health and Human Services. Medicaid Special Coverage Conditions. Breast and Cervical Cancer: Prevention and Treatment. Available at http:\/\/www.cms.hhs.gov\/MedicaidSpecialCovCond\/02_BreastandCervicalCancer_PreventionandTreatment.asp . Accessed 29 March 2008."},{"key":"9134_CR60","unstructured":"CDC. Racial and ethnic approaches to community health (REACH) 2010. The Centers for Disease Control and Prevention 2007. Available at http:\/\/www.cdc.gov\/reach . Accessed 8 January 2008."},{"issue":"8 Suppl","key":"9134_CR61","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.22162","volume":"107","author":"HP Freeman","year":"2006","unstructured":"Freeman, H. P., & Vydelingum, N. A. (2006). The role of the special populations networks program in eliminating cancer health disparities. Cancer, 107(8 Suppl), 1933\u20131935.","journal-title":"Cancer"},{"issue":"8 Suppl","key":"9134_CR62","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/cncr.22164","volume":"107","author":"FE Jackson","year":"2006","unstructured":"Jackson, F. E., Chu, K. C., & Garcia, R. (2006). Special Populations Networks\u2014how this innovative community-based initiative affected minority and underserved research programs. Cancer, 107(8 Suppl), 1939\u20131944.","journal-title":"Cancer"},{"key":"9134_CR63","first-page":"1","volume":"56","author":"CDC","year":"2007","unstructured":"CDC. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56, 1\u201324.","journal-title":"MMWR"},{"issue":"11","key":"9134_CR64","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","volume":"95","author":"LL Villa","year":"2006","unstructured":"Villa, L. L., Costa, R. L., Petta, C. A., et al. (2006). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5\u00a0years of follow-up. British Journal of Cancer, 95(11), 1459\u20131466.","journal-title":"British Journal of Cancer"},{"issue":"19","key":"9134_CR65","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","volume":"356","author":"The Future II Study Group","year":"2007","unstructured":"The Future II Study Group. (2007). Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New England Journal of Medicine, 356(19), 1915\u20131927.","journal-title":"New England Journal of Medicine"},{"key":"9134_CR66","unstructured":"Haupt, R. M. Gardasil update: End-of-study and adult women. Paper presented at ACIP, Atlanta, GA, 27 Feb 2008."},{"issue":"26","key":"9134_CR67","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","volume":"25","author":"SE Olsson","year":"2007","unstructured":"Olsson, S. E., Villa, L. L., Costa, R. L., et al. (2007). Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like particle (VLP) vaccine. Vaccine, 25(26), 4931\u20134939.","journal-title":"Vaccine"},{"issue":"27\u201328","key":"9134_CR68","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","volume":"24","author":"LL Villa","year":"2006","unstructured":"Villa, L. L., Ault, K. A., Giuliano, A. R., et al. (2006). Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18. Vaccine, 24(27\u201328), 5571\u20135583.","journal-title":"Vaccine"},{"issue":"33\u201334","key":"9134_CR69","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1016\/j.vaccine.2006.06.005","volume":"24","author":"SL Giannini","year":"2006","unstructured":"Giannini, S. L., Hanon, E., Moris, P., et al. (2006). Enhanced humoral and memory B cellular immunity using HPV16\/18 L1 VLP vaccine formulated with the MPL\/aluminium salt combination (AS04) compared to aluminium salt only. Vaccine, 24(33\u201334), 5937\u20135949.","journal-title":"Vaccine"},{"key":"9134_CR70","doi-asserted-by":"crossref","unstructured":"Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmer\u00f3n, J., Wheeler, C. M., et al., for the HPV PATRICIA study group. (2007). Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial. Lancet, 369(9580), 2161\u20132170.","DOI":"10.1016\/S0140-6736(07)60946-5"},{"issue":"9518","key":"9134_CR71","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","volume":"367","author":"DM Harper","year":"2006","unstructured":"Harper, D. M., Franco, E. L., Wheeler, C. M., et al. (2006). Sustained efficacy up to 4.5\u00a0years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet, 367(9518), 1247\u20131255.","journal-title":"Lancet"},{"key":"9134_CR72","unstructured":"Harper, D., Gall, S., Naud, P., et\u00a0al. (2008). Sustained immunogenicity and high efficacy against HPV-16\/18 related cervical neoplasia: Long-term follow up through 6.4 years in women vaccinated with cervarix TM (GSK\u2019s HPV 16\/18 AS04 Candidate Vaccine). Paper presented at SGO Conference, Tampa, FL, 2008."},{"key":"9134_CR73","unstructured":"Gall, S., Teixeira, J., Wheeler, C., Naud, P., Harper, D. M., Franco, E. L., et al., on behalf of the HPV Vaccine Study Group. Substantial impact on precancerous lesions and HPV infections through 5.5\u00a0years in women vaccinated with the HPV-16\/18 L1 VLP AS04 candidate vaccine. In Proceedings of the AACR Annual Meeting 2007. Available at http:\/\/www.aacr.org\/home\/scientists\/meetings-workshops\/annual-meeting-2007\/publications.aspx . Accessed 18 April 2008."},{"key":"9134_CR74","unstructured":"Schwarz, T. F., & Dubin, G. (2007). Women HVSIfA. Human papillomavirus (HPV) 16\/18 AS04 virus-like particle (VLP) cervical cancer vaccine is immunogenic and well tolerated 18\u00a0months after vaccination in women up to 55\u00a0years. Journal of Clinical Oncology 2007 ASCO Annual Meeting Proceedings Part I 2007, 25, (18S (June 20 Supplement))."}],"container-title":["Journal of Community Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-008-9134-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10900-008-9134-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-008-9134-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:10:22Z","timestamp":1559265022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10900-008-9134-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,24]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["9134"],"URL":"https:\/\/doi.org\/10.1007\/s10900-008-9134-4","relation":{},"ISSN":["0094-5145","1573-3610"],"issn-type":[{"value":"0094-5145","type":"print"},{"value":"1573-3610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,24]]}}}